IMU 1.89% 5.2¢ imugene limited

Why IMU is a multi multi bagger, page-18032

  1. 13,812 Posts.
    lightbulb Created with Sketch. 2339

    Eli Lily gets key prescription weigh-loss approval

    The US Food and Drug Administration approved Eli Liliy's weight loss drug on Wednesday.

    The drug approved, tirzepatide, had already been approved for Type 2 diabetes under the trade name Mounjaro. The drug recently contributed to Eli Lily's boosted sales outlook as demand for prescription weight loss drugs has been a hot topic on Wall Street. Goldman Sachs estimated 15 million Americans will be taking weight loss drugs by 2030.

    Eli Lily (LLY) shares popped more than 1% on the news while competitor Novo Nordisk (NVO) saw shares slide more than 1%.

 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.